GLP-1 medications are used to manage Type 2 diabetes and obesity by mimicking a hormone that regulates blood sugar levels and appetite
Dostalova, I., Haluzikova, D
Clinical Evidence: GLP-1 Treatment for NAFLD in the UK Emerging clinical evidence suggests GLP-1 receptor agonists may offer therapeutic benefits for patients with NAFLD and NASH, though it is important to note that these medications are not currently licensed specifically for liver disease treatment in the UK
Key takeaways Chinas GLP-1 market is booming, driven by rising diabetes and obesity prevalence, expanded indications (e.g., MASH, CKD, Alzheimers), policy support and momentum from global leaders and innovative local players
Whether youre considering a prescription weight loss medication or looking for immediate wellness support, we offer personalized programs and quick-access supplements designed to fit your unique needs
Tall, leafy oaks that have lined the street for decades are set to be cut down